BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21544856)

  • 1. Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.
    Weiss BM; Minter A; Abadie J; Howard R; Ascencao J; Schechter GP; Kuehl M; Landgren O
    Am J Hematol; 2011 Jun; 86(6):475-8. PubMed ID: 21544856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting.
    Singh J; Dudley AW; Kulig KA
    J Lab Clin Med; 1990 Dec; 116(6):785-9. PubMed ID: 2246554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.
    Greenberg AJ; Vachon CM; Rajkumar SV
    Leukemia; 2012 Apr; 26(4):609-14. PubMed ID: 22193966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.
    Landgren O; Rajkumar SV; Pfeiffer RM; Kyle RA; Katzmann JA; Dispenzieri A; Cai Q; Goldin LR; Caporaso NE; Fraumeni JF; Blot WJ; Signorello LB
    Blood; 2010 Aug; 116(7):1056-9. PubMed ID: 20421448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and progression risk factors for patients with monoclonal gammopathy of undetermined significance].
    Guan A; Shen KN; Zhang L; Cao XX; Su W; Zhou DB; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):137-140. PubMed ID: 36948868
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
    Xu A; Guo T; Zhang S; Luo H; Shen M; Ye Y; Ji L
    Hematology; 2024 Dec; 29(1):2352686. PubMed ID: 38819332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
    Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
    Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Current Standard of Practice Serum Free Light Chains (sFLC) Reference Interval Puts Black Patients at 5 Times Higher Odds for Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
    Azimi V; Fiala MA; Zaydman MA
    Clin Chem; 2023 Sep; 69(9):1084-1086. PubMed ID: 37366327
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.
    Katzmann JA; Clark R; Kyle RA; Larson DR; Therneau TM; Melton LJ; Benson JT; Colby CL; Dispenzieri A; Landgren O; Kumar S; Bradwell AR; Cerhan JR; Rajkumar SV
    Leukemia; 2013 Jan; 27(1):208-12. PubMed ID: 22781594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
    Turesson I; Kovalchik SA; Pfeiffer RM; Kristinsson SY; Goldin LR; Drayson MT; Landgren O
    Blood; 2014 Jan; 123(3):338-45. PubMed ID: 24222331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.
    Landgren O; Graubard BI; Kumar S; Kyle RA; Katzmann JA; Murata K; Costello R; Dispenzieri A; Caporaso N; Mailankody S; Korde N; Hultcrantz M; Therneau TM; Larson DR; Cerhan JR; Rajkumar SV
    Blood Cancer J; 2017 Oct; 7(10):e618. PubMed ID: 29053158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
    Landgren O; Zeig-Owens R; Giricz O; Goldfarb D; Murata K; Thoren K; Ramanathan L; Hultcrantz M; Dogan A; Nwankwo G; Steidl U; Pradhan K; Hall CB; Cohen HW; Jaber N; Schwartz T; Crowley L; Crane M; Irby S; Webber MP; Verma A; Prezant DJ
    JAMA Oncol; 2018 Jun; 4(6):821-827. PubMed ID: 29710195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
    N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria.
    Lewis E; Lee H; Fine N; Miller R; Hahn C; Tay J; Chhibber S; Mahe E; Jimenez-Zepeda VH
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):211-217. PubMed ID: 36621346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.